1. Home
  2. BWAY vs SLDB Comparison

BWAY vs SLDB Comparison

Compare BWAY & SLDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BrainsWay Ltd.

BWAY

BrainsWay Ltd.

HOLD

Current Price

$25.45

Market Cap

451.2M

Sector

Health Care

ML Signal

HOLD

Logo Solid Biosciences Inc.

SLDB

Solid Biosciences Inc.

HOLD

Current Price

$6.56

Market Cap

444.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BWAY
SLDB
Founded
2003
2013
Country
Israel
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
451.2M
444.9M
IPO Year
2019
2018

Fundamental Metrics

Financial Performance
Metric
BWAY
SLDB
Price
$25.45
$6.56
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
10
Target Price
$26.50
$14.70
AVG Volume (30 Days)
119.9K
1.0M
Earning Date
03-10-2026
03-05-2026
Dividend Yield
N/A
N/A
EPS Growth
213.09
N/A
EPS
0.13
N/A
Revenue
$49,094,000.00
N/A
Revenue This Year
$330.76
N/A
Revenue Next Year
$22.24
N/A
P/E Ratio
$77.54
N/A
Revenue Growth
27.08
N/A
52 Week Low
$7.84
$2.41
52 Week High
$25.16
$7.37

Technical Indicators

Market Signals
Indicator
BWAY
SLDB
Relative Strength Index (RSI) 70.20 62.56
Support Level $22.90 $6.35
Resistance Level $24.78 $6.95
Average True Range (ATR) 1.23 0.40
MACD 0.07 0.12
Stochastic Oscillator 95.76 80.79

Price Performance

Historical Comparison
BWAY
SLDB

About BWAY BrainsWay Ltd.

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

About SLDB Solid Biosciences Inc.

Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. The company's pipeline products are the SB-001 and solid suit. The Company's singular focus is on developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.

Share on Social Networks: